N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide

C27H29FN4O3S — CID 118023413

IUPACN-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide
SMILESO=S(=O)(NC1CN(c2ccc3c(c2)C(Cc2ccccc2)C(N2CCC2)CO3)C1)c1cccnc1F
InChIInChI=1S/C27H29FN4O3S/c28-27-26(8-4-11-29-27)36(33,34)30-20-16-32(17-20)21-9-10-25-23(15-21)22(14-19-6-2-1-3-7-19)24(18-35-25)31-12-5-13-31/h1-4,6-11,15,20,22,24,30H,5,12-14,16-18H2
InChIKeyXEJCQANOOAUWRK-UHFFFAOYSA-N
MW508.62 g/mol
LogP3.18
Rot. Bonds7

About N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide

N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide (PubChem CID 118023413) has the molecular formula C27H29FN4O3S and a molecular weight of 508.62 g/mol. Its IUPAC name is N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide.

Molecular Properties

Compound NameN-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide
PubChem CID118023413
Molecular FormulaC27H29FN4O3S
Molecular Weight508.62 g/mol
Exact Mass508.19
IUPAC NameN-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide
SMILESO=S(=O)(NC1CN(c2ccc3c(c2)C(Cc2ccccc2)C(N2CCC2)CO3)C1)c1cccnc1F
InChIInChI=1S/C27H29FN4O3S/c28-27-26(8-4-11-29-27)36(33,34)30-20-16-32(17-20)21-9-10-25-23(15-21)22(14-19-6-2-1-3-7-19)24(18-35-25)31-12-5-13-31/h1-4,6-11,15,20,22,24,30H,5,12-14,16-18H2
InChIKeyXEJCQANOOAUWRK-UHFFFAOYSA-N
XLogP3.18
TPSA74.77 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500508.62
LogP ≤ 53.18
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide?
The IUPAC name of N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide (CID 118023413) is N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide.
What is the SMILES notation for N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide?
The canonical SMILES for N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide is O=S(=O)(NC1CN(c2ccc3c(c2)C(Cc2ccccc2)C(N2CCC2)CO3)C1)c1cccnc1F.
What is the InChIKey of N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide?
The InChIKey is XEJCQANOOAUWRK-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H29FN4O3S/c28-27-26(8-4-11-29-27)36(33,34)30-20-16-32(17-20)21-9-10-25-23(15-21)22(14-19-6-2-1-3-7-19)24(18-35-25)31-12-5-13-31/h1-4,6-11,15,20,22,24,30H,5,12-14,16-18H2.
What are the key properties of N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide?
N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide has a molecular weight of 508.62 g/mol, XLogP of 3.18, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[3-(azetidin-1-yl)-4-benzyl-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]-2-fluoropyridine-3-sulfonamide is sourced from PubChem (CID 118023413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).